Novel highly potent growth hormone secretagogues were identified through systematic optimization, achieving nanomolar potency with improved pharmacological properties for GH deficiency treatment.
Key findingSystematic optimization produced novel GH secretagogue compounds with high nanomolar potency at the ghrelin receptor, improved pharmacological propert
What the researchers found
Systematic optimization produced novel GH secretagogue compounds with high nanomolar potency at the ghrelin receptor, improved pharmacological properties, and validated GH release in animal models — advancing the GH secretagogue drug pipeline.
Why it matters
Relevant for ghrp, peptide-design, hormone-optimization.
How the study worked
animal-study study on ghrp, peptide-design.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2007.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Highly potent growth hormone secretagogues.
Bioorganic & medicinal chemistry letters, 17(13), 3657-9
Citation
Lu, Zhijian; Tata, James R; Cheng, Kang; Wei, Liente; Chan, Wanda W-S; Butler, Bridget; Schleim, Klaus D; Jacks, Thomas M; Hickey, Gerard; Patchett, Arthur A. (2007). Highly potent growth hormone secretagogues.. Bioorganic & medicinal chemistry letters, 17(13), 3657-9.